Peptide density targets and impedes triple negative breast cancer metastasis
The C-X-C chemokine receptor type 4 (CXCR4) pathway is a key regulator of cancer metastasis. Here, the authors present a method to block CXCR4 and thereby inhibit breast cancer metastasis by developing a liposome that presents CXCR4-binding peptides in a multivalent fashion.
Saved in:
Main Authors: | Daxing Liu, Peng Guo, Craig McCarthy, Biran Wang, Yu Tao, Debra Auguste |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/34668309ab9d4d19b8e724f40b74daac |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
by: Wen-Hung Kuo, et al.
Published: (2012) -
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition
by: Elizabeth Garcia, et al.
Published: (2021) -
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
by: Gloria V. Echeverria, et al.
Published: (2018) -
RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis
by: Zhuming Yin, et al.
Published: (2021) -
RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
by: Kyoungwha Pang, et al.
Published: (2019)